Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
5
Bearish filings
0
Named actors
5
Disclosed $ (bull / bear)
$558K / $0
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-12 | Director HOMBACH ROBERT J. | bought | $224K | SEC ↗ |
| 2026-08-12 | Pres, Pharm Svc&Prod Mgmt, CLO Mann Jeffrey Z | bought | $100K | SEC ↗ |
| 2026-08-12 | SVP and CFO Elguicze Jacob | bought | $93K | SEC ↗ |
| 2026-08-12 | President and CEO Kurdikar Devdatt | bought | $141K | SEC ↗ |
| 2026-04-29 | 5%+ holder (13G) VANGUARD CAPITAL MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals